Study in vitro and in vivo of nociceptin/orphanin FQ(1-13)NH2 analogues substituting N-Me-Gly for Gly2 or Gly3

Peptides

Volumn 25, Issue 8, 2004, Pages 1349-1354

  Chen, Li Xiang ^a   Fang, Quan ^a   Chen, Qiang ^a   Guo, Jia ^a   Wang, Zhuan Zi ^a   Chen, Yong ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Nphe1 NC(1 13)NH2; Mouse vas deferens (MVD); Naloxone; Orphanin FQ nociceptin; Sarcosine; Tail flick test

Indexed keywords

GLYCINE; GLYCINE DERIVATIVE; NALOXONE; NOCICEPTIN; NOCICEPTIN DERIVATIVE; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; SARCOSINE; TETRAPEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DRUG SYNTHESIS; HYDROPHOBICITY; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SUBSTITUTION; ANIMALS; GLYCINE; MALE; MICE; OLIGOPEPTIDES; OPIOID PEPTIDES; PAIN MEASUREMENT; SARCOSINE; STRUCTURE-ACTIVITY RELATIONSHIP; VAS DEFERENS;

EID: 4444331111     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.05.012     Document Type: Article

References (16)

1. 2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol. 349:1998;5-6
2. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J. Med. Chem. 41:1998;3360-3366
3. 2, a new selective nociceptin receptor antagonist. Br. J. Pharmacol. 129:2000;1183-1193
4. Calo G., Rizzi A., Bigoni R., Neugebauer V., Salvadori S., Guerrini R., et al. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol. 311:1996;R3-R5
5. Guerrini R., Calo G., Rizzi A., Bianchi C., Lazarus L.H., Salvadori S., et al. Address and message sequence for the nociceptin receptor: a structure-activity study of nociceptin(1-13)peptide amide. J. Med. Chem. 40:1997;1789-1793
6. Guerrini R., Calo G., Rizzi A., Bigoni R., Bianchi C., Salvadori S., et al. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123:1998;163-165
7. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15
8. 2 and orphanin FQ/nociceptin (OFQ/NC) produce similar cardiovascular and renal responses in conscious rats. J. Pharmacol. Exp. Ther. 289:1999;173-180
9. Meunier J.C., Mollereau C., Tool L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535
10. 2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells. Neuroreport. 10:1999;1127-1131
11. 2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br. J. Pharmacol. 127:1999;121-130
12. Polidori C., Calo G., Ciccocioppo R., Guerrini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology (Berl). 148:2000;430-437
13. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Hernningsen R.A., Bunzow J.R., et al. Orohanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794
14. 2 antagonizes nociceptin effects in the mouse colon. Eur. J. Pharmacol. 385:1999;R3-R5
15. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur. J. Pharmacol. 311:1996;R7-R8
16. Rossi G.C., Leventhal L., Bolan E., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282:1997;858-865